|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.50 CNY | -0.79% |
|
-5.30% | -10.39% |
| 06-09 | China Approves Aodong Subsidiary's Levocarnitine Injection | MT |
| 05-21 | Jilin Aodong Pharmaceutical Gets China Approval for Supplemental Registration of Heart Drug | MT |
| Market Cap | 20.52B 3.03B 2.65B 2.46B 2.26B 4.28B 290B 4.36B 29.3B 11.49B 142B 11.36B 11.11B 491B | P/E 2024 |
13.1x | P/E 2025 | 9.57x |
|---|---|---|---|---|---|
| Enterprise Value | 19.79B 2.92B 2.56B 2.37B 2.18B 4.13B 279B 4.21B 28.26B 11.08B 137B 10.96B 10.72B 474B | EV / Sales 2024 |
7.76x | EV / Sales 2025 | 9.49x |
| Free-Float |
67.59% | Yield 2024 |
2.9% | Yield 2025 | 2.56% |
| 1 day | -0.79% | ||
| 1 week | -5.30% | ||
| Current month | -1.30% | ||
| 1 month | +0.63% | ||
| 3 months | -4.06% | ||
| 6 months | -13.92% | ||
| Current year | -10.39% |
| 1 week | 17.32 |  | 18.7 |
| 1 month | 17.08 | | 18.88 |
| Current year | 16.36 | | 20.93 |
| 1 year | 16.36 | | 22.08 |
| 3 years | 12.49 | | 22.08 |
| 5 years | 12.49 | | 22.08 |
| 10 years | 12.49 | | 29.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 63 | 2017-07-16 |
Kai Yang
DFI | Director of Finance/CFO | 49 | 2004-04-30 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 54 | 2007-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Lin Li
CHM | Chairman | 73 | 2005-05-17 |
Shu Qin Guo
BRD | Director/Board Member | 63 | 2000-01-31 |
Yong Feng Chen
CHM | Chairman | 59 | 2017-07-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-24 | Buy | 100 | 0.0000% | |||
| 24-07-28 | Buy | Chairman | 350,000 | 0.0302% | ||
| 24-07-28 | Buy | Chief Executive Officer | 320,000 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | -5.30% | -1.41% | +11.54% | 3.05B | |
| +0.00% | -0.76% | +49.00% | +173.98% | 1,060B | |
| +0.32% | -0.53% | +64.50% | +62.44% | 619B | |
| -0.46% | -3.18% | +28.79% | +84.63% | 438B | |
| -1.75% | -0.33% | +28.33% | +23.58% | 333B | |
| +0.24% | -0.42% | +29.19% | +47.26% | 282B | |
| -1.75% | -10.57% | +18.27% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -1.34% | -2.14% | +20.73% | +57.52% | 196B | |
| +0.87% | +1.10% | +16.90% | +70.82% | 161B | |
| Average | -0.34% | -3.31% | +22.75% | +51.59% | 357.7B | |
| Weighted average by Cap. | -0.20% | -3.10% | +35.76% | +84.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.61B 385M 338M 313M 288M 544M 36.85B 555M 3.73B 1.46B 18.1B 1.45B 1.41B 62.5B | 2.34B 344M 302M 280M 257M 487M 32.96B 496M 3.33B 1.31B 16.19B 1.29B 1.26B 55.9B |
| Net income | 1.55B 229M 201M 186M 171M 323M 21.9B 330M 2.22B 869M 10.75B 859M 840M 37.14B | 2.4B 353M 310M 287M 264M 499M 33.81B 509M 3.42B 1.34B 16.6B 1.33B 1.3B 57.34B |
| Net Debt | -386M -56.92M -49.93M -46.24M -42.55M -80.48M -5.45B -82.04M -551M -216M -2.68B -214M -209M -9.24B | -724M -107M -93.65M -86.74M -79.81M -151M -10.22B -154M -1.03B -405M -5.02B -401M -392M -17.33B |
Employees
5,461
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-12 | CN¥17.50 | -0.79% | 12,861,090 |
| 26-07-10 | CN¥17.64 | -1.07% | 14,006,300 |
| 26-07-09 | CN¥17.83 | +0.73% | 12,360,059 |
| 26-07-08 | CN¥17.70 | -1.99% | 10,420,598 |
| 26-07-07 | CN¥18.06 | -3.73% | 13,183,515 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 000623 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
